Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
Titel:
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study
Auteur:
Kakolyris, S. Papadakis, E. Tsiafaki, X. Kalofonos, C. Rapti, A. Toubis, M. Bania, E. Kouroussis, Ch. Chainis, K. Androulakis, N. Agelaki, S. Sarra, E. Vardakis, N. Georgoulias, V.